Writing here as a board member for the Multidisciplinary Association of Psychedelic Studies (MAPS), it’s been a crazy few months. I have no doubt that the Food & Drug Administration will eventually approve MDMA-assisted therapy for PTSD after more clinical research hoops are jumped through, but the media and cultural hysteria that preceded their disappointing decision to delay approval was hard to watch…